Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39651 - 39675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ethinylestradiol	Approved Investigational	TSC22D3	1831	downregulated	Ethinyl Estradiol results in decreased expression of TSC22D3 mRNA	Xq22.3	A22574
Ethinylestradiol	Approved Investigational	TSPAN1	10103	downregulated	Ethinyl Estradiol results in decreased expression of TSPAN1 mRNA	1p34.1	A22574
Ethinylestradiol	Approved Investigational	VDAC1	7416	upregulated	Ethinyl Estradiol results in increased expression of VDAC1 mRNA	5q31.1	A22574
Ethinylestradiol	Approved Investigational	VGLL1	51442	downregulated	Ethinyl Estradiol results in decreased expression of VGLL1 mRNA	Xq26.3	A22574
Ethinylestradiol	Approved Investigational	VWF	7450	downregulated	Ethinyl Estradiol results in decreased expression of VWF mRNA	12p13.31	A22574
Ethinylestradiol	Approved Investigational	ZBTB7C	201501	downregulated	Ethinyl Estradiol results in decreased expression of ZBTB7C mRNA	18q21.1	A22574
Mestranol	Approved Withdrawn	ABHD2	11057	upregulated	Mestranol results in increased expression of ABHD2 mRNA	15q26.1	A21106
Mestranol	Approved Withdrawn	ALAD	210	downregulated	Mestranol results in decreased expression of ALAD mRNA	9q32	A21106
Mestranol	Approved Withdrawn	AREG	374	upregulated	Mestranol results in increased expression of AREG mRNA	4q13.3	A21106
Mestranol	Approved Withdrawn	CA12	771	upregulated	Mestranol results in increased expression of CA12 mRNA	15q22.2	A21106
Mestranol	Approved Withdrawn	CCND1	595	upregulated	Mestranol results in increased expression of CCND1 mRNA	11q13.3	A21106
Mestranol	Approved Withdrawn	CCNG2	901	downregulated	Mestranol results in decreased expression of CCNG2 mRNA	4q21.1	A21106
Mestranol	Approved Withdrawn	CD44	960	upregulated	Mestranol results in increased expression of CD44 mRNA	11p13	A21106
Mestranol	Approved Withdrawn	CLMN	79789	downregulated	Mestranol results in decreased expression of CLMN mRNA	14q32.13	A21106
Mestranol	Approved Withdrawn	CXCL12	6387	upregulated	Mestranol results in increased expression of CXCL12 mRNA	10q11.21	A21106
Mestranol	Approved Withdrawn	DYRK2	8445	downregulated	Mestranol results in decreased expression of DYRK2 mRNA	12q15	A21106
Mestranol	Approved Withdrawn	EFNA1	1942	downregulated	Mestranol results in decreased expression of EFNA1 mRNA	1q22	A21106
Mestranol	Approved Withdrawn	EGR3	1960	upregulated	Mestranol results in increased expression of EGR3 mRNA	8p21.3	A21106
Mestranol	Approved Withdrawn	EPHA4	2043	downregulated	Mestranol results in decreased expression of EPHA4 mRNA	2q36.1	A21106
Mestranol	Approved Withdrawn	FHL2	2274	upregulated	Mestranol results in increased expression of FHL2 mRNA	2q12.2	A21106
Mestranol	Approved Withdrawn	FOXC1	2296	upregulated	Mestranol results in increased expression of FOXC1 mRNA	6p25.3	A21106
Mestranol	Approved Withdrawn	ID3	3399	downregulated	Mestranol results in decreased expression of ID3 mRNA	1p36.12	A21106
Mestranol	Approved Withdrawn	JAK2	3717	upregulated	Mestranol results in increased expression of JAK2 mRNA	9p24.1	A21106
Mestranol	Approved Withdrawn	KYNU	8942	downregulated	Mestranol results in decreased expression of KYNU mRNA	2q22.2	A21106
Mestranol	Approved Withdrawn	MICAL2	9645	upregulated	Mestranol results in increased expression of MICAL2 mRNA	11p15.3	A21106

Displaying entries 39651 - 39675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability